Ithaka Group’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.63M | Buy |
105,626
+2,193
| +2% | +$153K | 1.38% | 25 |
|
|
2025
Q4 | $6.86M | Buy |
103,433
+1,250
| +1% | +$80.8K | 1.22% | 29 |
|
|
2025
Q3 | $6.88M | Sell |
102,183
-386
| -0.4% | -$30.5K | 1.17% | 28 |
|
|
2025
Q2 | $8.95M | Sell |
102,569
-7,101
| -6% | -$557K | 1.53% | 22 |
|
|
2025
Q1 | $7.49M | Buy |
109,670
+448
| +0.4% | +$36.6K | 1.53% | 24 |
|
|
2024
Q4 | $8.49M | Sell |
109,222
-1,351
| -1% | -$100K | 1.56% | 24 |
|
|
2024
Q3 | $7.41M | Sell |
110,573
-8,084
| -7% | -$664K | 1.41% | 25 |
|
|
2024
Q2 | $13.5M | Sell |
118,657
-885
| -0.7% | -$112K | 2.48% | 16 |
|
|
2024
Q1 | $16.6M | Buy |
119,542
+8,551
| +8% | +$1.07M | 3.13% | 12 |
|
|
2023
Q4 | $13.8M | Sell |
110,991
-2,116
| -2% | -$216K | 2.72% | 15 |
|
|
2023
Q3 | $10.6M | Sell |
113,107
-4,023
| -3% | -$453K | 2.43% | 16 |
|
|
2023
Q2 | $15.1M | Sell |
117,130
-20,660
| -15% | -$2.5M | 3.14% | 13 |
|
|
2023
Q1 | $16M | Sell |
137,790
-161,204
| -54% | -$18M | 3.37% | 11 |
|
|
2022
Q4 | $33.9M | Buy |
298,994
+131,269
| +78% | +$14.4M | 3.89% | 9 |
|
|
2022
Q3 | $13.5M | Sell |
167,725
-1,952
| -1% | -$165K | 3.01% | 14 |
|
|
2022
Q2 | $12.6M | Sell |
169,677
-8,507
| -5% | -$776K | 2.53% | 17 |
|
|
2022
Q1 | $22.8M | Buy |
178,184
+408
| +0.2% | +$44.6K | 3.16% | 13 |
|
|
2021
Q4 | $23.9M | Sell |
177,776
-3,592
| -2% | -$516K | 2.91% | 16 |
|
|
2021
Q3 | $24.8M | Sell |
181,368
-5,844
| -3% | -$737K | 3.03% | 14 |
|
|
2021
Q2 | $20M | Sell |
187,212
-2,160
| -1% | -$207K | 2.42% | 18 |
|
|
2021
Q1 | $17M | Sell |
189,372
-31,216
| -14% | -$2.93M | 2.31% | 17 |
|
|
2020
Q4 | $20.4M | Buy |
220,588
+2,172
| +1% | +$194K | 2.27% | 20 |
|
|
2020
Q3 | $22.5M | Sell |
218,416
-656
| -0.3% | -$68.5K | 2.78% | 15 |
|
|
2020
Q2 | $22.2M | Buy |
219,072
+204
| +0.1% | +$18.2K | 3.05% | 13 |
|
|
2020
Q1 | $14.7M | Sell |
218,868
-5,568
| -2% | -$346K | 2.81% | 15 |
|
|
2019
Q4 | $12.3M | Sell |
224,436
-73,580
| -25% | -$3.49M | 2.06% | 22 |
|
|
2019
Q3 | $11.1M | Buy |
298,016
+28,228
| +10% | +$1.1M | 1.57% | 25 |
|
|
2019
Q2 | $10.1M | Buy |
269,788
+7,580
| +3% | +$238K | 1.53% | 26 |
|
|
2019
Q1 | $7.81M | Buy |
+262,208
| New | +$9.21M | 1.24% | 27 |
|
|
2017
Q3 | – | Sell |
-325,664
| Closed | -$5.96M | – | 41 |
|
|
2017
Q2 | $5.96M | Buy |
325,664
+2,812
| +0.9% | +$51.9K | 1.08% | 31 |
|
|
2017
Q1 | $6.84M | Sell |
322,852
-15,172
| -4% | -$296K | 1.32% | 29 |
|
|
2016
Q4 | $5.04M | Sell |
338,024
-73,736
| -18% | -$1.31M | 0.99% | 34 |
|
|
2016
Q3 | $9.02M | Buy |
+411,760
| New | +$9.16M | 1.42% | 28 |
|
Other funds holding DXCM
VCM
VPM
Ithaka Group's DXCM Position: Q1 2026 in Review
Ithaka Group increased its DexCom (DXCM) stake by 2.1% in Q1 2026, buying an estimated $153K and bringing the position to 105,626 shares worth $6.63M. The position accounts for 1.38% of the portfolio, ranked #25.
Ithaka Group first reported a position in DXCM in Q3 2016 and has held it in 33 quarters since. The position peaked at $33.9M in Q4 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Ithaka Group held 105,626 shares of DexCom worth $6.63M as of Q1 2026.
- Ithaka Group bought 2,193 DexCom shares in Q1 2026, an estimated $153K.
- DexCom made up 1.38% of Ithaka Group's portfolio in Q1 2026, its #25 holding.
- Ithaka Group first reported a position in DexCom in Q3 2016 and has held it in 33 quarters since.
- Ithaka Group's DexCom position peaked at $33.9M in Q4 2022.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Ithaka Group's 13F filing for Q1 2026, filed 12 May 2026.